Rivaroxaban an anticoagulant agent appears to have a role in reversing the hypoxia-induced metabolic adaptation observed in colorectal cancer cell lines

Bayrak Ö., Bayrak S.

FEBS-YSF-2024, Milan, Italy, 26 - 29 June 2024, pp.55, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• City: Milan
• Country: Italy
• Page Numbers: pp.55
• Dokuz Eylül University Affiliated: Yes